Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
ANECTINE (succinylcholine chloride) is a depolarizing neuromuscular blocking agent administered by injection used primarily as an adjunct to anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery. It works by mimicking acetylcholine at the neuromuscular junction, causing initial depolarization followed by sustained depolarization that prevents muscle contraction.
As a mature product approaching loss of exclusivity with moderate competitive pressure (45/100), career focus will increasingly shift toward cost containment and retention strategies rather than growth expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on ANECTINE offers stability in a legacy franchise with deep clinical integration in perioperative settings, but limited upside for career growth in traditional commercial or development tracks. Career value lies in specialized expertise in neuromuscular pharmacology, safety management, and hospital system relationships in an increasingly generic-dominated market.
Worked on ANECTINE at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.